Special report: cost-effectiveness studies of new hepatitis C treatments.
作者信息
Mark David H
出版信息
Technol Eval Cent Assess Program Exec Summ. 2015 Jan;29(10):1-3.
PMID:25962188
Abstract
摘要
相似文献
1
Special report: cost-effectiveness studies of new hepatitis C treatments.特别报道：新型丙型肝炎治疗方法的成本效益研究
Technol Eval Cent Assess Program Exec Summ. 2015 Jan;29(10):1-3.
2
The price of good health.健康的代价。
Nat Med. 2014 Apr;20(4):319. doi: 10.1038/nm.3538.
3
[Therapy spectrum in hepatitis C extended. Newer NS3/4A protease inhibitor in chronic hepatitis C-GT1/4 infection].[丙型肝炎治疗范围扩大。慢性丙型肝炎基因1/4型感染中新型NS3/4A蛋白酶抑制剂]
MMW Fortschr Med. 2014 Jun 12;156 Suppl 1:53.
4
Cost-effectiveness of novel regimens for the treatment of hepatitis C virus.新型丙型肝炎病毒治疗方案的成本效益分析。
Ann Intern Med. 2015 Mar 17;162(6):407-19. doi: 10.7326/M14-1152.
5
WHO issues guidelines on HCV amid drug cost controversy.在药物成本争议中，世界卫生组织发布了关于丙型肝炎病毒的指南。
JAMA. 2014 Jun 11;311(22):2262-3. doi: 10.1001/jama.2014.5277.
6
[A new era in therapy of chronic hepatitis C].[慢性丙型肝炎治疗的新时代]
MMW Fortschr Med. 2015 Feb 5;157(2):38. doi: 10.1007/s15006-015-2641-1.
7
[New combination therapy increases chances of recovery].[新的联合疗法增加康复机会]
MMW Fortschr Med. 2015 Feb 19;157(3):70. doi: 10.1007/s15006-015-2714-1.
8
The comparative clinical effectiveness and value of simeprevir and sofosbuvir for chronic hepatitis C virus infection.西米普明和索非布韦治疗慢性丙型肝炎病毒感染的比较临床疗效和价值。
JAMA Intern Med. 2014 Jul;174(7):1170-1. doi: 10.1001/jamainternmed.2014.2151.
9
Medicine. Hepatitis C can be cured globally, but at what cost?医学。丙型肝炎在全球范围内都可以治愈，但代价是什么呢？
Science. 2014 Jul 11;345(6193):141-2. doi: 10.1126/science.1257737.
10
[Chronic hepatitis C. Interferon free therapy also in patients with liver cirrhosis].[慢性丙型肝炎。无干扰素疗法也适用于肝硬化患者]
MMW Fortschr Med. 2014 Dec 15;156(21-22):97.
Zotero 插件